Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults

Condition:   Healthy VolunteersInterventions:   Biological: NoV GI.1/GII.4 Bivalent VLP Vaccine;   Biological: NoV vaccine placeboSponsor:   TakedaNot yet recruiting - verified January 2016

Source: ClinicalTrials.gov - January 27, 2016 Category: Research Source Type: clinical trials